Northern Trust Corp Oncternal Therapeutics, Inc. Transaction History

Northern Trust Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.63 - $1.3 $1,766 - $3,645	2,804 Added 3.42%	84,706 $66,000
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.56 $204,150 - $454,963	-291,643 Reduced 78.07%	81,902 $91,000
Q1 2022 May 13, 2022	SELL	$1.37 - $2.43 $31,552 - $55,965	-23,031 Reduced 5.81%	373,545 $519,000
Q4 2021 Feb 08, 2022	SELL	$2.27 - $4.39 $391,475 - $757,081	-172,456 Reduced 30.31%	396,576 $900,000
Q3 2021 Nov 15, 2021	SELL	$3.37 - $4.76 $69,465 - $98,117	-20,613 Reduced 3.5%	569,032 $2.37 Million
Q2 2021 Aug 13, 2021	BUY	$4.75 - $9.39 $2.4 Million - $4.74 Million	505,180 Added 598.09%	589,645 $2.8 Million
Q1 2021 May 12, 2021	BUY	$4.59 - $9.04 $184,215 - $362,811	40,134 Added 90.53%	84,465 $703,000
Q4 2020 Feb 11, 2021	BUY	$1.51 - $6.3 $44,040 - $183,745	29,166 Added 192.32%	44,331 $217,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $3.28 $2,216 - $4,277	1,304 Added 9.41%	15,165 $26,000
Q2 2020 Aug 14, 2020	BUY	$2.43 - $3.23 $673 - $894	277 Added 2.04%	13,861 $40,000
Q4 2019 Feb 14, 2020	BUY	$3.75 - $6.11 $50,940 - $82,998	13,584 New	13,584 $54,000
Q3 2019 Nov 13, 2019	SELL	$3.87 - $6.13 $42,922 - $67,987	-11,091 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$4.86 - $9.24 $53,902 - $102,480	11,091 New	11,091 $73,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.